The cost of relapse in schizophrenia and schizoaffective disorder

Australas Psychiatry. 2009 Aug;17(4):265-72. doi: 10.1080/10398560903002998.

Abstract

Objective: The aim of this study was to quantify the costs and resource utilization associated with a relapse of schizophrenia or schizoaffective disorder.

Methods: The study comprised a retrospective audit of data from 200 patients diagnosed with schizophrenia or schizoaffective disorder who were admitted to hospital for a relapse of their disorder in two mental health services in Australia between 1 June 2001 and 31 May 2002. Resource use and costing data were collected for 12 months before and 12 months after the hospitalization.

Results: There was an increase in contacts per month and associated outpatient costs after the index admission which persisted for the full 12 month data collection period (total of AUD $637). There was also a total increase in hospital costs but this did not persist beyond the first 2 months of the follow-up period and is likely explained by the index admission.

Conclusions: Increased healthcare resource utilization and costs results from relapse in patients with schizophrenia or schizoaffective disorder. An increase in service use and costs persist for a considerable time period after an episode of relapse.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antipsychotic Agents / therapeutic use
  • Australia / epidemiology
  • Cost of Illness
  • Data Interpretation, Statistical
  • Female
  • Hospitalization / economics
  • Humans
  • Length of Stay / economics
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Patient Compliance
  • Proportional Hazards Models
  • Psychotic Disorders / drug therapy
  • Psychotic Disorders / economics*
  • Psychotic Disorders / epidemiology
  • Recurrence
  • Retrospective Studies
  • Schizophrenia / drug therapy
  • Schizophrenia / economics*
  • Schizophrenia / epidemiology
  • Young Adult

Substances

  • Antipsychotic Agents